Skip to content
Screener

DaVita DVA Q2 2026 earnings

Reported August 4, 2026 · After market close

Revenue$3.6BBeat by $57.7M
EPS$4.02Beat by $0.14
Revenue estimate$3.5B
EPS estimate$3.88
“Thanks to the outstanding efforts of our teammates, we had another positive quarter for both patient outcomes and financial results. As we look to the rest of the year, we maintain our strategic focus on exciting new innovations in kidney dialysis to enhance the lives of our patients.”
Javier Rodriguez

Next report

Nov 4, 2026 (in a month)
Revenue estimate$3.5B
EPS estimate$3.55

Valuation & ratios

Valuation

as of 10/02/26
See full
Market cap$11.16B+19.1%
Enterprise value$23.77B+11.0%
P/E14.3×+2.1×
P/S0.8×+0.1×

FAQ

When did DaVita report Q2 2026 earnings?
DaVita (DVA) reported Q2 2026 earnings on August 4, 2026 after market close.
What were DaVita's Q2 2026 revenue and EPS?
DaVita reported revenue of $3.6B and eps of $4.02 for Q2 2026.
Did DaVita beat estimates in Q2 2026?
Revenue beat the consensus estimate of $3.5B by $57.7M. EPS beat the consensus estimate of $3.88 by $0.14.
How did DaVita's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.2% from $3.4B a year earlier and eps grew 36.3% from $2.95.
Where can I find DaVita's Q2 2026 SEC filings?
You can read the 8-K earnings release (0000927066-26-000105) and the 10-Q periodic report (0000927066-26-000108) directly on SEC EDGAR. The filing index links above go to sec.gov.